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ABSTRACT The AP-5 complex is a recently identified but evolutionarily ancient member of 
the family of heterotetrameric adaptor proteins (AP complexes). It is associated with two 
proteins that are mutated in patients with hereditary spastic paraplegia, SPG11 and SPG15. 
Here we show that the four AP-5 subunits can be coimmunoprecipitated with SPG11 and 
SPG15, both from cytosol and from detergent-extracted membranes, with a stoichiometry of 
∼1:1:1:1:1:1. Knockdowns of SPG11 or SPG15 phenocopy knockdowns of AP-5 subunits: all 
six knockdowns cause the cation-independent mannose 6-phosphate receptor to become 
trapped in clusters of early endosomes. In addition, AP-5, SPG11, and SPG15 colocalize on a 
late endosomal/lysosomal compartment. Both SPG11 and SPG15 have predicted secondary 
structures containing α-solenoids related to those of clathrin heavy chain and COPI subunits. 
SPG11 also has an N-terminal, β-propeller–like domain, which interacts in vitro with AP-5. We 
propose that AP-5, SPG15, and SPG11 form a coat-like complex, with AP-5 involved in pro-
tein sorting, SPG15 facilitating the docking of the coat onto membranes by interacting with 
PI3P via its FYVE domain, and SPG11 (possibly together with SPG15) forming a scaffold.
INTRODUCTION
AP-5 is the most recently identified and the least well characterized 
of the heterotetrameric adaptor protein (AP) complexes (Hirst et al., 
2011). Its subunits share so little sequence identity with the subunits 
of the other AP complexes that they cannot be found using stan-
dard bioinformatics tools such as BLAST, and so for many years the 
existence of a fifth AP complex was unsuspected. However, struc-
tural prediction programs indicate that the subunits of AP-5 adopt 
similar folds to their counterparts in APs 1–4, and so their nomencla-
ture follows the same convention: ζ and β5 for the two large sub-
units, μ5 for the medium subunit, and σ5 for the small subunit, en-
coded by the genes AP5Z1, AP5B1, AP5M1, and AP5S1, respectively. 
Like all of the AP complexes, AP-5 is evolutionarily ancient (Hirst 
et al., 2011) and ubiquitously expressed (http://biogps.org/, www 
.ncbi.nlm.nih.gov/UniGene/), although its expression profile in de-
veloping chick embryos (Hirst et al., 2013) suggests that it may be 
particularly important in neurons.
Characterization of AP-5 has been somewhat hampered by its 
low abundance (Hirst et al., 2013) and absence from a number of 
model organisms (Hirst et al., 2011). However, an important insight 
into its function came from the discovery by Słabicki et al. (2010) that 
AP-5 subunits could be coimmunoprecipitated with two proteins 
mutated in patients with hereditary spastic paraplegia (HSP), SPG11 
and SPG15 (also known as spatacsin and spastizin/ZFYVE26/FYVE-
CENT, respectively). HSP is a group of genetic disorders character-
ized by progressive spasticity in the lower limbs. Mutations in SPG11 
and SPG15 are the major causes of HSP accompanied by thin cor-
pus callosum and mental impairment (Boukhris et al., 2008), and 
patients with mutations in these two genes present with the same 
clinical features. In addition, morpholino knockdowns of SPG11 and 
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SPG15 in zebrafish produce very similar phenotypes, affecting the 
development of motor neurons (Martin et al., 2012). Both observa-
tions are consistent with the two proteins acting together in the 
same pathway. Furthermore, Słabicki et al. (2010) discovered that 
mutations in AP5Z1 are also associated with HSP, although in this 
case the patients had a later onset of the disease.
Both SPG11 and SPG15 are large proteins (>250 kDa), and 
SPG15 has a FYVE domain that binds in vitro to phosphatidylinositol 
3-phosphate (PI3P; Sagona et al., 2010). Little is known about the 
precise functions of the two proteins or how they associate with AP-
5. In addition, there is some controversy over the localization of 
SPG11 and SPG15, with labeling reported in many different loca-
tions, including endoplasmic reticulum, endosomes, microtubules, 
mitochondria, nuclei, and the midbody of dividing cells (Hanein 
et al., 2008; Sagona et al., 2010; Murmu et al., 2011). In the present 
study, we use a combination of biochemistry and microscopy to be-
gin to dissect the structural and functional relationship between AP-
5, SPG11, and SPG15.
RESULTS
Stable association of SPG11/SPG15 with AP-5
We previously generated a HeLa cell line expressing green fluores-
cent protein (GFP)–tagged σ5 and showed by Western blotting that 
when cytosol from these cells is immunoprecipitated with anti-GFP, 
other AP-5 subunits coprecipitate (Hirst et al., 2011). To identify ad-
ditional AP-5–associated proteins, we have analyzed our σ5-GFP 
immunoprecipitates by mass spectrometry and also carried out im-
munoprecipitations on cells expressing GFP-tagged ζ, SPG15, and 
SPG11.
In the σ5-GFP immunoprecipitates, we identified >50 proteins, 
but only 6 of these were specifically brought down in cells express-
ing σ5-GFP and not in control cells, and these were the ζ, β5, μ5, 
and σ5 subunits of AP-5, together with SPG11 and SPG15 (Supple-
mental Table S1). To investigate the interaction further, we used the 
Quantitative BAC InteraCtomics (QUBIC) method, which allows the 
sensitive and unbiased detection of protein–protein interactions 
(Hubner et al., 2010). Triplicate immunoprecipitations were per-
formed on three BAC transgenic cell lines expressing GFP-tagged 
SPG11, SPG15, or AP-5 ζ from their endogenous promoters. Pre-
cipitated proteins were identified by mass spectrometry and com-
pared with immunoprecipitations performed on a control cell line, 
using label-free quantification. Proteins specifically associated with 
the bait were thus readily distinguished from nonspecific back-
ground proteins (Figure 1A). The only proteins that were consistently 
and specifically coprecipitated with all three baits were the four 
AP-5 subunits, SPG11, and SPG15.
We also used the proteomic data to estimate the relative abun-
dance of the precipitated proteins (Figure 1B). Our data indicate 
that all six proteins are present in equal copy numbers. In turn, this 
suggests that AP-5 is part of a stable hexameric complex consisting 
of one AP-5 tetramer and one copy each of SPG11 and SGP15.
The identification of AP-5 subunits in the SPG15-GFP immuno-
precipitate was confirmed by Western blotting, which also showed 
that these interactions occur in cytosol, as well as on membranes 
(Figure 2A). The coprecipitation of SPG11 and SPG15 with cytosolic 
AP-5 indicates a very stable association because under the same 
conditions, clathrin does not coimmunoprecipitate with AP-1 or 
AP-2 (Figure 2B).
SPG11 or SPG15 knockdown phenocopies AP-5 knockdown
If SPG11 and SPG15 are associated with AP-5, they might be ex-
pected to have similar knockdown phenotypes. We previously 
showed by immunofluorescence that knockdown of any of the AP-5 
subunits results in perturbed trafficking of the cation-independent 
mannose 6-phosphate receptor (CIMPR), causing it to become 
trapped in clusters of endosomes that are positive for EEA1 and the 
retromer subunit Vps26 (Hirst et al., 2011; Figure 3). Knocking down 
either SPG11 or SPG15 produces a similar phenotype (Figure 3A), 
which we quantified by automated microscopy (Figure 3B; see Sup-
plemental Figure S1 for Western blots of the knockdowns). In all 
three knockdowns, labeled structures appeared larger, brighter, and 
fewer, most likely due to endosomal clustering (Hirst et al., 2011). 
This phenotype could be observed not only with the small interfer-
ing RNA (siRNA) pool but also with single, nonoverlapping siRNAs 
(Supplemental Figure S2) and was slightly more pronounced for 
SPG15 than for SPG11. Knockdown of SPG15 (but not SPG11) also 
resulted in the tubulation of EEA1-positive endosomes (Supplemen-
tal Figure S2). Although the significance of the tubulation pheno-
type is unclear, knocking down another HSP protein, strumpellin, 
also causes endosomes to tubulate (Harbour et al., 2010).
Localization of SPG11 and SPG15
In our previous study on AP-5, we carried out immunolocalization 
studies on cells expressing either μ5-GFP or σ5-GFP and saw punc-
tate labeling that partially overlapped with the late endosomal/
lysosomal marker LAMP1. We also saw nuclear labeling for σ5-GFP 
but not for μ5-GFP. This is most likely due to excess nonassembled 
σ5-GFP, which is sufficiently small (<50 kDa) to diffuse freely into 
the nucleus (Hirst et al., 2011; Figure 4A). We found that GFP-
tagged SPG15 and SPG11 had a similar pattern but without the 
nuclear background, including overlap with LAMP1 (Figure 4A and 
Supplemental Figure S3). There have been conflicting reports 
about the localization of SPG11 and SPG15, however, and there is 
always the danger that tagged constructs may be mislocalized. 
Therefore, we made monoclonal antibodies against both SPG11 
and the AP-5 ζ subunit to investigate the distribution of the endog-
enous proteins. Antibodies against both proteins labeled puncta 
distributed throughout the cytoplasm in human fibroblasts and in 
SPG15-GFP–expressing HeLa cells (Figure 4, B and C, and Supple-
mental Figure S4), and double labeling for endogenous SPG11 
and LAMP1 again showed substantial overlap (Figure 4B). This 
punctate labeling pattern was lost when the proteins were de-
pleted using siRNA (Supplemental Figure S4), confirming the spec-
ificity of the antibodies. There was also substantial colocalization 
between SPG15-GFP and endogenous ζ and SPG11 (Figure 4C). 
To investigate whether there is any overlap with some of the other 
structures that have been reported to colocalize with SPG15 and/
or SPG11, we labeled our cells expressing the tagged constructs 
with markers for early endosomes, centrosomes, and endoplasmic 
reticulum exit sites but did not see coincident labeling (Supple-
mental Figure S5).
We also carried out live-cell imaging on the SPG15-GFP–
expressing cells and found that the puncta were dynamic in nature, 
with long-range as well as short-range movements (Figure 5A and 
Supplemental Movie S1). When the cells were incubated with either 
Lysotracker Red or Magic Red Cathepsin B (Figure 5B and Supple-
mental Movies S2 and S3), we found almost complete overlap with 
SPG15-GFP. This indicates that the SPG15 compartment is acidic 
and contains active hydrolases. In addition, localization of SPG15-
GFP by immunogold electron microscopy (EM) showed labeling of 
structures that often contained membrane whorls (Figure 5C). To-
gether, these data show that AP-5, SPG11, and SPG15 localize to 
organelles that can be morphologically, enzymatically, and bio-
chemically defined as late endosomes/lysosomes.
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Dependence of AP-5 on SPG11 and 
SPG15
To investigate whether AP-5, SPG11, and 
SPG15 are dependent on each other for 
their localization and/or stability, we 
knocked down one protein and then looked 
for effects on the others by immunofluores-
cence microscopy. Knockdown of either 
SPG11 or SPG15 resulted in a dramatic loss 
of σ5-GFP punctate labeling, comparable 
to the loss of σ5-GFP labeling when other 
subunits of AP-5 are knocked down 
(Figure 6A). Western blotting indicated that 
AP-5 subunits may be destabilized when 
SPG15 is depleted (Supplemental Figure 
S1), so the loss of punctate AP-5 labeling 
could result from effects on stability, recruit-
ment, or both. In contrast, knocking down 
AP-5 subunits produced little or no effect 
on the localization of GFP-tagged SPG15 or 
SPG11. We also observed that AP-5 ζ label-
ing was brighter in cells expressing SPG15-
GFP (Figure 4C), suggesting that increasing 
the expression of SPG15 increases the 
membrane localization of AP-5. Thus AP-5 
appears to depend on SPG11/SPG15 for its 
localization and/or stability but not vice 
versa.
A number of vesicle coat proteins, in-
cluding AP-1, AP-3, and AP-4, require the 
small GTPase ARF1 to localize to mem-
branes, and become cytosolic when cells 
are treated with the drug brefeldin A, which 
inhibits guanine nucleotide exchange fac-
tors for ARF1. Neither AP-5 nor SPG15 is 
affected by brefeldin A (Hirst et al., 2011; 
Figure 6B), however, indicating that their 
localization to membranes is ARF1 inde-
pendent. The plasma membrane adaptor 
AP-2 is also ARF1 independent, but it re-
quires a specific phosphoinositide for its 
FIGURE 1: Stable association of SPG11 and SPG15 with AP-5. (A) QUBIC interaction proteomic 
analysis. GFP-tagged AP-5 ζ, SPG11, and SPG15 were stably expressed under the control of 
their endogenous promoters. Immunoprecipitations were performed with an anti-GFP antibody 
and compared by label-free quantitative mass spectrometry with immunoprecipitations (IPs) 
performed on a control cell line with no GFP bait protein. Every experiment was performed in 
triplicate. Data were analyzed with a t test to determine significant interactions (Hubner et al., 
2010) and visualized in a “volcano plot.” For each identified protein, plots show the fold 
difference in abundance (bait IP vs. control IP; x-axis, log2 scale), as well as a p-value indicating 
robustness of the observed difference (y-axis, –log10 scale). Specific interactors have high fold 
differences and low p values (top right quadrant of the plot). The “volcano” lines indicate the 
significance cut-off that separates specific interactors from background. With every bait, all four 
AP-5 subunits, SPG11, and SPG15 are specifically coimmunoprecipitated. The SPG11 bait also 
coIPs a number of abundant cytoskeletal proteins, but since these proteins were not identified 
in the other two QUBIC experiments, it seems unlikely that these interactions are physiologically 
relevant. Furthermore, the SPG11 pull down has a greater scatter of background proteins 
than the AP-5 ζ and SGP15 pull downs, suggesting that it may be slightly less specific. 
(B) Stoichiometry analysis. Normalized peptide intensities were used to estimate the relative 
abundance of specific interactors identified in A (iBAQ method; Schwanhäusser et al., 2011). 
For each protein, the values from all triplicate repeats were plotted. Only coimmunoprecipitated 
proteins were included, since the bait protein 
tends to be overrepresented in 
immunoprecipitation experiments. The 
relative abundances of proteins were 
normalized to the median abundance of all 
proteins across each experiment (i.e., median 
set to 1.0). The data show that regardless of 
the bait protein, roughly equal molar 
amounts of AP-5 subunits, SPG11, and 
SPG15 are coprecipitated, which supports 
the existence of an equimolar hexameric 
complex consisting of AP-5, SPG11, and 
SPG15. The only exception is a substantially 
higher proportion of AP-5 σ precipitated 
with AP-5 ζ (top). Based on structural 
information on other AP complexes (Page 
and Robinson, 1995; Collins et al., 2002), 
these two subunits may form a stable 
subcomplex, and expression of tagged AP-5 
ζ may thus stabilize and increase the 
recovery of AP-5 σ.
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FIGURE 2: Western blots of immunoprecipitates. (A) Immunoprecipitations were carried out on 
either control HeLa cells or HeLa cells expressing SPG15-GFP using anti-GFP, and the blots were 
probed using antibodies against AP-5 subunits. AP-5 coprecipitates with SPG15-GFP in both a 
high-speed supernatant of homogenized cells (SUP) and a Triton X-100 extract of a high-speed 
pellet (PEL), indicating that the association occurs both in cytosol and on membranes. The 
lower–molecular weight band in the immunoprecipitates probed with anti-β5 appears to be 
nonspecific. (B) A cytosol fraction from SPG15-GFP–expressing cells was immunoprecipitated 
with the antibodies indicated at the top, and Western blots were probed with the antibodies 
indicated at the side. Although AP-5 coimmunoprecipitates with SPG15-GFP, AP-1 and AP-2 do 
not coimmunoprecipitate with clathrin heavy chain (CHC). The input is 2.5% relative to the IP for 
SPG15-GFP and 5% for CHC, AP-1, and AP-2.
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localization, phosphatidylinositol 4,5-bisphosphate, which is mainly 
generated on the plasma membrane (Beck and Keen, 1991; Honing 
et al., 2005). SPG15 has been shown to bind in vitro to another 
phosphoinositide, PI3P (Sagona et al., 2010), which is found mainly 
on endosomes. To investigate the importance of this interaction in 
vivo, we treated cells with the phosphoinositide (PI) 3-kinase inhibi-
tor wortmannin. The punctate patterns of both SPG15-GFP and 
σ5-GFP were lost under these conditions (Figure 6B), indicating 
that PI3P is required for the recruitment of both SPG15 and AP-5, 
most likely by interacting with the FYVE domain of SPG15.
AP-5 interacts with the N-terminal domain of SPG11
We previously showed that AP-5 does not colocalize with clathrin 
and cannot be detected in clathrin-coated vesicle-enriched fractions 
(Hirst et al., 2011), indicating that if it is a component of a vesicle 
coat, it must use some other type of scaffold. It is intriguing that 
both SPG11 and SPG15 are predicted to contain α-helical solenoids, 
similar to those of clathrin heavy chain, the α and β′ subunits of the 
COPI coat, and the Sec31 subunit of the COPII coat (Devos et al., 
2004). In clathrin, COPI, and COPII, the α-solenoid is preceded by a 
β-propeller, and SPG11 also has a predicted N-terminal, β-propeller–
like fold. In addition, HHpred (Söding et al., 2005) identifies clathrin 
heavy chain, α-COP, and β′-COP as matches for both the α-solenoid 
and the β-propeller regions (Figure 7, A and B).
The β-propeller of clathrin heavy chain is a major hub for protein–
protein interactions (Lemmon and Traub, 2012), with binding part-
ners including AP-1, AP-2, and several “alternative adaptors.” To 
determine whether the β-propeller–like domain of SPG11 also acts 
as a binding platform, we carried out a glutathione S-transferase 
(GST) pull down on HeLa cell cytosol, using residues 1–500 of SPG11 
as bait. We were able to detect the ζ subunit of AP-5 by Western 
blotting (Figure 7C), indicating that a similar type of interaction at-
taches AP-5 to SPG11. As controls, we probed for the γ subunit of 
AP-1 and the α subunit of AP-2. Even though AP-1 and AP-2 are 
∼30- and ∼70-fold more abundant in HeLa 
cells than AP-5 (Hirst et al., 2013), respec-
tively, they could not be detected in the pull 
down.
DISCUSSION
By analogy with other AP complexes, it 
seems likely that the role of AP-5 is to act as 
a cargo adaptor for a novel type of coat. 
Other components of the coat may include 
proteins that form a docking site to facilitate 
recruitment onto membranes and proteins 
that can assemble into some sort of scaf-
fold. We propose that SPG15 and SPG11 
function as a docking site and scaffold, 
respectively.
The interaction between AP-5 and 
SPG11/SPG15 was initially demonstrated 
by immunoprecipitation. We extended 
these observations to determine whether 
the proteins are associated with each other 
in cytosol as well as on membranes, deter-
mine their stoichiometry, and look for other 
binding partners. We found that the four 
AP-5 subunits, SPG11, and SPG15 invari-
ably coimmunoprecipitate with each other, 
without pulling down any other proteins, 
and can be coimmunoprecipitated from cy-
tosol, as well as from membrane extracts. This is in contrast to AP-1/
AP-2 and clathrin, which only interact on membranes and do not 
efficiently coimmunoprecipitate even from membrane extracts. 
Thus AP-5 and SPG11/SPG15 are more like the COPI coat in this 
respect, where there is a relatively stable complex, called the 
coatomer, which can be dissociated into two subcomplexes (Pavel 
et al., 1998). SPG11 and SPG15 appear to be in an equimolar ratio 
with the four AP-5 subunits, which again is reminiscent of coatomer, 
where all seven subunits are stoichiometric with each other.
In addition to coimmunoprecipitating with AP-5, SPG11 and 
SPG15 have similar knockdown phenotypes to the AP-5 subunits. In 
every case, the CIMPR becomes trapped in membrane clusters that 
are positive for EEA1 and Vps26, indicating that they are early endo-
somal compartments. AP-5, SPG11, and SPG15 also have very simi-
lar subcellular distributions, localizing to a late endosomal/lysosomal 
compartment. This pattern can be seen with antibodies against en-
dogenous proteins, as well as with tagged constructs, and it is 
strongly reduced when the proteins are depleted with siRNA, dem-
onstrating that the labeling is specific. The identity of the compart-
ment is based on several lines of evidence: the label shows substan-
tial overlap with LAMP1; it colocalizes with both Lysotracker Red, a 
vital stain for acidic organelles, and Magic Red Cathepsin B, a vital 
stain for organelles containing active hydrolases; and by immuno-
gold EM it is associated with structures containing membrane 
whorls. Thus, although knocking down the proteins produces 
changes in an early endosomal compartment, the proteins them-
selves localize (at least primarily) to a later compartment.
The connection between SPG11/SPG15/AP-5 and HSP indicates 
that a loss of these proteins is particularly deleterious to neurons with 
long axons because these are the cells that are primarily affected. Late 
endosomes and lysosomes are found mostly in the neuronal cell body, 
but some are present in axons, where they are transported mainly in 
the retrograde direction (Tsukita and Ishikawa, 1980; Cai et al., 2010). 
Whether mutations in AP-5, SPG11, or SPG15 affect axonal trafficking 
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FIGURE 3: Knockdown of SPG11 and SPG15 phenocopies AP-5 knockdown. (A) HeLa cells were treated with siRNAs as 
indicated and double labeled for the CIMPR and the retromer protein Vps26. In the siRNA-treated cells, the CIMPR 
clusters in Vps26-positive endosomes. There also appears to be increased colocalization of CIMPR and Vps26 in these 
cells. All of the images of siRNA-treated cells were taken at half the exposure time of the controls because of the 
increased brightness. Scale bar, 20 μm. (B) The knockdown phenotypes were quantified using an ArrayScan VTI 
microscope and Spot Detector V4 algorithm application for automated image collection and analysis. Means of CIMPR 
labeling in control and knockdown cells were compared using repeated-measures analysis of variance and the post hoc 
Tukey–Kramer significance test (*p < 0.05, **p < 0.01, ***p < 0.001). More than 1500 cells were scored per knockdown 
condition (two independent repeats). In every knockdown, there is an increase in the area and intensity of spots and a 
concomitant decrease in the number of spots (although the decrease in spot number could be a result of increased 
clustering rather than fewer structures).
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FIGURE 4: Immunofluorescence labeling of AP-5, SPG15, and SPG11. (A) Cells stably expressing either σ5-GFP or 
SPG15-GFP were fixed and double labeled with antibodies against GFP (to enhance the signal) and the late endosomal/
lysosomal protein LAMP1. Cytosolic σ5-GFP was washed out by saponin before fixation, leaving nuclear staining (this 
construct is likely to diffuse freely in and out of the nucleus). The punctate GFP labeling throughout the cytoplasm is 
partially coincident with LAMP1. (B) Primary human fibroblasts were double labeled for endogenous SPG11 and LAMP1. 
The two antibodies show good colocalization. (C) Cells expressing SPG15-GFP were fixed and double labeled with 
anti-GFP and monoclonal antibodies against either SPG11 or ζ subunit of AP-5. The labeling patterns for tagged SPG15 
and endogenous ζ or SPG11 are largely coincident. Scale bars, 20 μm.
of these organelles or cause HSP for some other reason (e.g., by im-
pairing axonal maintenance) remains to be determined.
The PI 3-kinase inhibitor wortmannin causes AP-5, SPG11, and 
SPG15 to appear cytosolic rather than membrane associated, indi-
cating that the phosphoinositide PI3P acts as a membrane identity 
marker, most likely by binding to the FYVE domain of SPG15. 
Although PI3P is usually regarded as marker for an early endosomal 
compartment, there is at least one other protein, sorting nexin 16 
(Snx16), that binds to PI3P (via a PX domain) but localizes to a late 
endosomal compartment (Brankatschk et al., 2011). In the case of 
Snx16, another domain also contributes to localization (Hanson and 
Hong, 2003), and it seems likely that additional interactions will be 
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FIGURE 5: SPG15 localization. (A) Stills from a movie (Supplemental Movie S1) showing cells expressing SPG15-GFP. 
Cells were imaged every 10 s over 15 min. Motile structures can be seen moving over short (arrows) and long distances 
(circle). Scale bar, 20 μm. (See Supplemental Movie S1.) (B) Cells expressing SPG15-GFP were either incubated with 
Lysotracker Red, a vital stain for acidic organelles, and imaged immediately, or incubated with Magic Red Cathepsin B 
substrate, a vital stain for active lysosomal hydrolases, for 30 min and then imaged. SPG15-GFP colocalizes with both 
markers. Scale bar: 20 μm. (See Supplemental Movies S2 and S3.) (C) Immunogold labeling of SPG15-GFP–expressing 
cells. Because of the low abundance of the protein, labeling was sparse, but there was very little background. Gold 
particles can be seen associated with organelles containing membrane whorls, characteristic of late endosomes/
lysosomes, but we did not find any label associated with budding profiles. Scale bar, 200 nm.
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SPG11 or SPG15. Most organisms have either both AP-5 and 
SPG11/SPG15 or neither, but there are a few exceptions, including 
Drosophila, that have SPG11/SPG15 but not AP-5 (Hirst et al., 2011). 
Thus it is possible that SPG11/SPG15 may be able to function in the 
absence of AP-5. The observation that patients with mutations in 
found to facilitate the binding of SPG11/SPG15 to late endosomes, 
similar to the “coincidence detection” mechanism used to recruit 
AP-2 onto membranes (Haucke, 2005).
Although knockdown of SPG11 or SPG15 affects the localization 
of AP-5, knocking down AP-5 does not affect the localization of 
FIGURE 6: Localization of AP-5 depends on SPG11/SPG15 and is sensitive to wortmannin. (A) Cells stably expressing 
σ5-GFP, SPG15-GFP, or SPG11-GFP were treated with siRNAs and then labeled with anti-GFP. The σ5-GFP–expressing 
cells were treated with saponin before fixation to wash out cytosolic proteins. The punctate labeling of σ5-GFP is lost 
when ζ, SPG11, or SPG15 is depleted. In contrast, the punctate labeling of SPG15-GFP or SPG11-GFP is not lost when 
ζ is depleted. SPG15 labeling becomes diffuse when SPG11 is depleted, however, and SPG11 labeling becomes diffuse 
when SPG15 is depleted. In both cases, siRNAs targeting the construct itself (plus the endogenous version of the 
protein) strongly reduce the total fluorescence. (B) Cells stably expressing either SPG15-GFP or σ5-GFP were treated 
with 5 μg/ml brefeldin A (BFA) for 5 min or 100 nM wortmannin for 1 h and then fixed. The σ5-GFP–expressing cells 
were treated with saponin to wash out cytosolic proteins before fixation. The punctate labeling of both proteins is 
insensitive to brefeldin A but is lost upon treatment with wortmannin. Scale bars, 20 μm.
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FIGURE 7: Domain organization of SPG15 and SPG11. (A) The domain organization of SPG15 was predicted by 
DOMpred, and then homology searching with each domain was carried out using HHpred (http://toolkit.tuebingen 
.mpg.de/hhpred). More information about the HHpred hits is available in Supplemental Table S2. PSIpred was used to 
carry out a secondary structure prediction for each residue. The α-helices are in magenta and β-strands in cyan. The 
height of each colored vertical line is proportional to the confidence of the secondary structure prediction (McGuffin 
et al., 2000). (B) A similar analysis was carried out on SPG11. (C) GST alone or the N-terminal domain of SPG11 coupled 
to GST was incubated with HeLa cell cytosol, and bound AP-5 ζ was detected by Western blotting. The N-terminal 
domain of SPG11 (GST-SPG11N) pulls down AP-5 ζ from cytosol. We estimate, however, that no more than ∼10% of the 
total AP-5 ζ was pulled down by the SPG11 construct, probably because most of the AP-5 already has SPG11 stably 
associated with it, so the pull down only captures “unoccupied” AP-5. As controls, blots of the cytosol and pull downs 
were also probed with antibodies against the AP-1 γ and AP-2 α subunits. Although both of these proteins are much 
more abundant in cytosol than AP-5 ζ, neither was detected in the GST-SPG11N pull down.
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(Carlsbad, CA). Monoclonal antibodies were raised against peptides 
from AP5Z1 (1H1) and SPG11 (4C10, 4L15, 3I13) by Abmart (Shang-
hai, China). Sixteen peptide immunogens for either SPG11 or ζ were 
overexpressed in Escherichia coli, purified by Ni-affinity chromatog-
raphy, and injected into BALB/C mice. Spleen cells were fused with 
SP2/0 myeloma cells, and selected clonal cell lines were used to 
produce ascites fluid, from which antibodies were purified by pro-
tein A/G affinity chromatography. Where known, the epitope is indi-
cated: 3I13 (KDHAKTSDPG), 4L15 (PVQNYKTKEG), and 4C10 
(PQELQGSKQE). The isotypes of the mouse monoclonal antibodies 
made for this study are immunoglobulin G2b (IgG2b; 1H1 and 
4C10), IgG2a (4L15), and IgG3 (3I13). The mouse monoclonals 
against EEA1, C-NAP1, and LAMP1 are all IgG1, and the mouse 
anti-GFP is IgG2a.
For pull-down experiments, a cDNA encoding residues 1–500 of 
SPG11 was cloned into pGEX4T-1 for expression of GST-SPG11N, 
and the resulting fusion protein (which was partially insoluble and 
degraded) was purified using glutathione-Sepharose, as specified 
by the manufacturer (GE Healthcare, Piscataway, NJ).
RNA interference
Knockdowns were performed using the following On-Target Plus 
siRNA reagents from Dharmacon, Lafayette, CO) or a nontargeting 
SMARTpool siRNA (D-001810-10) as a control. The siRNAs were as 
follows: μ5 (C14orf108), J-015523-09, J-015523-10; ζ (KIAA0415), 
L-025284-01; SPG11 (FLJ21439), L-017138-00; SPG15 (ZFYVE26), 
J-031136-09, J-031136-10, J-031136-11, J-031136-12; all used at a 
concentration of 25 nM. Knockdowns were performed with a single-
hit 72-h protocol using Oligofectamine (Invitrogen) and Opti-Mem 
(Invitrogen) following the manufacturer’s instructions.
Tissue culture
HeLaM cells (Tiwari et al., 1987) were grown in DMEM (Sigma-Al-
drich) supplemented with 10% (vol/vol) fetal calf serum (Sigma-Al-
drich), 2 mM l-glutamine, 50 U/ml penicillin, and 50 μg/ml strepto-
mycin. A stable clonal cell line expressing σ5-GFP (Hirst et al., 2011) 
was derived by G418 selection. HeLa cells stably expressing GFP-
tagged SPG11, SPG15, and KIAA0415 (ζ) have been previously de-
scribed (Słabicki et al., 2010). Because of loss of expression over 
time in culture, the cells were sorted by flow cytometry for medium 
to high expression of GFP and maintained in G418-containing 
medium.
Fluorescence microscopy
For immunofluorescence microscopy, cells were plated into glass-
bottom dishes (MatTek, Ashland, MA) and treated where indicated 
with 5 μg/ml brefeldin A for 5 min, 100 nM wortmannin for 1 h, or 
0.05% (wt/vol) saponin in phosphate-buffered saline (PBS) for 1 min. 
The cells were then fixed with 3% formaldehyde, permeabilized with 
0.1% Triton X-100, and labeled as indicated. The cells were imaged 
with a Zeiss Axiovert 200 inverted microscope (Carl Zeiss, Jena, Ger-
many) using a Zeiss Plan Achromat 63× oil immersion objective (nu-
merical aperture 1.4), an OCRA-ER2 camera (Hamamatsu, Hama-
matsu, Japan), and Improvision Openlab software (PerkinElmer, 
Waltham, MA).
For live-cell microscopy, cells were plated into glass-bottom 
dishes (MatTek) and incubated in CO2-independent media with 50 nM 
Lysotracker Red DND-99 (Invitrogen) or Magic Red Cathepsin B 
substrate (AbD Serotec, Raleigh, NC), following manufacturer’s 
instructions. The cells were imaged on a Zeiss LSM710 confocal 
microscope with Zeiss ZEN software. Movie images were captured 
every 10 s for a period of up to 15 min.
AP-5 ζ/AP5Z1 have a later onset of HSP than patients with muta-
tions in SPG11 or SPG15 (Słabicki et al., 2010) is consistent with this 
possibility. However, only two AP5Z1-deficient patients from a single 
family have been identified, so more examples will be needed be-
fore firm conclusions can be drawn. Fifty-two different loci associ-
ated with HSP have been identified, but the causative genes have 
been found for only 31 of these (Finsterer et al., 2012), and there are 
likely to be other, as-yet-unidentified loci. Whole-genome or whole-
exome sequencing may be the most efficient way of identifying ad-
ditional HPS-causing mutations (Züchner, 2010; Bettencourt et al., 
2013; Gonzalez et al., 2013). AP5B1, AP5M1, and AP5S1 are prom-
ising candidates for some of the other HPS causative genes, espe-
cially since mutations in all four of the AP-4 subunit genes have been 
shown to cause a form of “complex” HSP (reviewed in Hirst et al., 
2013).
Unlike SPG15, SPG11 does not have any obvious functional do-
mains; however, its predicted secondary structure, consisting of a 
β-propeller–like N-terminal domain followed by an α-solenoid, to-
gether with its homology to other coat components, including clath-
rin, suggests that it may form some sort of scaffold. Clathrin uses its 
N-terminal β-propeller domain to interact with AP complexes, and 
our pull-down experiments suggest that the same is true for the in-
teraction between SPG11 and AP-5. It is interesting that this domain 
is missing in SPG11 from insects, which also lack AP-5. The α-
solenoids of SPG11 and SPG15 may interact with each other to form 
a scaffold, similar to the clathrin, COPI, and COPII coats. It is not 
clear, however, what the morphology of such a scaffold might be 
because the labeling we observe for tagged SPG15 does not ap-
pear to be associated with budding profiles, suggesting that the 
AP-5/SPG11/SPG15 complex may be more analogous to the flat, 
bilayered clathrin/ESCRT-0 coats on early endosomes (Raiborg 
et al., 2002), which are believed to hold cargo proteins in place 
rather than package them into vesicles.
If AP-5 is indeed involved in cargo selection, what cargo proteins 
does it sort? We had hoped to find candidates in our immunopre-
cipitates, but the only proteins that were clearly being brought down 
specifically were AP-5 subunits, SPG11, and SPG15. This result is 
not entirely unexpected because coat–cargo interactions are very 
transient and often difficult to capture. We have recently been able 
to use the “knocksideways” technique for rapid protein inactivation, 
followed by subcellular fractionation and comparative proteomics, 
to identify >50 cargo proteins that are dependent on AP-1 and/or 
GGA2 for efficient packaging into CCVs (Hirst et al., 2012). By using 
a similar approach on AP-5, SPG11, and SPG15, we hope to be able 
to establish the precise functions of each of these proteins.
MATERIALS AND METHODS
Antibodies and constructs
Antibodies used in this study include in-house antibodies against 
clathrin and AP-1 (Simpson et al., 1996) and commercial antibodies 
against EEA1 (E41120; BD Transduction Labs, Lexington, KY), 
LAMP1 (sc18821; Santa Cruz Biotechnology, Santa Cruz, CA), GFP 
(ab6556; Abcam, Cambridge, MA), CIMPR (ab2733; Abcam), C-
NAP1 (BD611375; BD Biosciences, San Diego, CA), AP-2 α (610502; 
BD Biosciences), and AP5Z1 (KIAA0415; sc139260; Santa Cruz Bio-
technology). Rabbit anti-GFP and sheep anti-SEC16A were kind 
gifts from Matthew Seaman (Cambridge Institute for Medical Re-
search, Cambridge, United Kingdom) and David Stephens (Univer-
sity of Bristol, Bristol, United Kingdom), respectively. Horseradish 
peroxidase–labeled secondary antibodies were purchased from 
Sigma-Aldrich (St. Louis, MO) and fluorescently labeled secondary 
antibodies (species and/or isotype specific) from Invitrogen 
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control cell lines reveals proteins specifically associated with the 
bait. QUBIC was performed essentially as described by Hubner 
et al. (2010). Anti-GFP immunoprecipitations of BAC and control cell 
lines were performed in triplicate. The precipitated proteins were 
analyzed by mass spectrometry and compared using label-free 
quantification. The following cell lines were analyzed. BAC cell lines: 
SGP11-GFP, AP-5 ζ-GFP (Słabicki et al., 2010), SPG15-GFP (origi-
nally established by Słabicki et al., 2010; we selected a clonal cell 
line from this); control cell line: derived from the SPG15-GFP cell 
line; we selected cells that had lost expression of the SPG15-GFP 
bait (as determined by immunofluorescence microscopy and West-
ern blotting). This control cell line therefore closely corresponds to 
the parental HeLa cells used to generate all of the BAC cell lines.
To gauge the stoichiometry of identified proteins, we used in-
tensity-based absolute quantification (iBAQ) estimation of protein 
abundance (Schwanhäusser et al., 2011; implemented in the Max-
Quant package by Cox and Mann, 2008). iBAQ sums the intensi-
ties of all identified peptides for each protein and normalizes the 
total intensity to the number of theoretically obtainable tryptic 
peptides of the protein. Unlike the original publication, we omitted 
a spike-in standard and assumed proportionality between the 
iBAQ intensity and protein molarity. iBAQ can be used to estimate 
the relative abundance of subunits in a protein complex (Arike 
et al., 2012). Although the accuracy of the method is limited, it can 
clearly distinguish between stoichiometric (1:1) and substoichio-
metric (<<1:1) interactions. For each individual pull down, iBAQ 
values of coimmunoprecipitated proteins were first normalized to 
the iBAQ value of the bait protein. Data from pull downs with the 
same bait (triplicate repeats) were then combined and iBAQ values 
normalized to the median iBAQ value of the set (excluding the bait 
protein). Values were then log-transformed and plotted 
(Figure 1B).
To quantify knockdown phenotypes, we used an automated 
ArrayScan VTI microscope (Cellomics/Thermo Fisher, Pittsburgh, 
PA) and the SpotDetector V4 assay algorithm. Cells were plated 
onto 96-well PerkinElmer microplates and stained with anti-CIMPR, 
followed by Alexa Fluor 488–donkey anti-mouse IgG and whole-cell 
stain (Invitrogen). The cells were imaged with a modified Zeiss Axio-
vert 200M inverted microscope, a Zeiss 40×/0.5 Achroplan objec-
tive, and a Hamamatsu OCRA-ER camera, and >1500 cells quanti-
fied for each condition using ARRAYSCAN software.
Electron microscopy
For immunogold electron microscopy, a clonal line of cells express-
ing SPG15-GFP was derived, permeabilized by immersion in liquid 
N2, and fixed by adding an equal volume of freshly prepared 8% 
paraformaldehyde/0.2% gluteraldehyde in 0.1 M phosphate buffer, 
pH 7.4. After 5 min the solution was removed and cells were post-
fixed in 4% paraformaldehyde/0.1% glutaraldehyde in 0.1 M phos-
phate buffer, pH 7.4, for 1 h at room temperature and further pro-
cessed as previously described (Hirst et al., 2009). Ultrathin sections 
were labeled with the commercial GFP antibody (see previous de-
scription), followed by protein A conjugated to colloidal gold 
(Utrecht University, Utrecht, Netherlands), and viewed using a Phil-
lips CM 100 transmission electron microscope (Philips Electron 
Optics, Cambridge, United Kingdom) at an operating voltage of 
80 kV.
Immunoprecipitation and GST pull-down experiments
For immunoprecipitations from whole-cell lysates, cells stably ex-
pressing σ5-GFP or SPG15-GFP were solubilized in PBS containing 
1% Triton X-100 and insoluble material removed before incubation 
with GFP-Trap (ChromoTek, Martinsried, Germany), according to 
the manufacturer’s instructions. For analysis by mass spectrometry, 
proteins were processed by filter-aided sample preparation solution 
digest (Wis´niewski et al., 2009), and the sample was analyzed by 
liquid chromatography–tandem mass spectrometry in an Orbitrap 
mass spectrometer (Thermo Scientific; Waltham, MA; Antrobus and 
Borner, 2011). For immunoprecipitations from cytosol and mem-
brane fractions, cells stably expressing SPG15-GFP were scraped in 
PBS and lysed by six passages through a 21-gauge needle/5-ml sy-
ringe. Nuclei and unbroken cells were removed by centrifugation at 
4000 × g for 5 min, and then membranes were recovered at 50,000 
× g for 1 h. The membrane pellet was solubilized in PBS containing 
1% Triton X-100 and clarified by centrifugation. Triton X-100 was 
also added to the supernatant to a concentration of 1%, and then 
both samples were incubated with GFP-Trap (ChromoTek) accord-
ing to the manufacturer’s instructions.
For GST pull-down experiments, cells were solubilized in PBS 
containing 1% NP40, and insoluble material was removed by cen-
trifugation at 20,000 × g for 30 min. Samples containing 5 mg of 
starting lysate were precleared with 50 μg/ml GST, followed by glu-
tathione–Sepharose. The lysates were then incubated with 50 μg/ml 
GST-SPG11N, followed by glutathione–Sepharose, and washed 
with PBS containing 1% NP40, followed by PBS. Bound proteins 
were eluted with SDS–PAGE loading buffer.
Several cell lines were analyzed by QUBIC. QUBIC is a recent 
proteomics method for unbiased and sensitive identification of pro-
tein–protein interactions (Hubner and Mann, 2011). It is based on 
the generation of stable cell lines that express a GFP-tagged, full-
length bait protein under control of its endogenous promoter. The 
tagged bait protein is expressed at near-physiological levels and 
can be immunoprecipitated with an anti-GFP antibody. Quantitative 
mass spectrometric analysis of immunoprecipitates from bait and 
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